Consolidated statement of comprehensive income
January 1 – June 30
|
millions of CHF |
|
|
2024 |
|
2023 |
|
|
|
Net income |
|
|
|
5.6 |
|
7.3 |
|
|
|
|
|
|
|
|
|
|
|
Items that are or may be reclassified subsequently to the income statement |
|
|
|
|
|
|
|
|
Cash flow hedges, net of tax |
|
|
|
–2.6 |
|
0.6 |
|
|
Currency translation differences |
|
|
|
16.0 |
|
–3.2 |
|
|
Total items that are or may be reclassified subsequently to the income statement |
|
|
|
13.4 |
|
–2.6 |
|
|
|
|
|
|
|
|
|
|
|
Items that will not be reclassified to the income statement |
|
|
|
|
|
|
|
|
Remeasurements of defined benefit plans, net of tax |
|
|
|
0.9 |
|
–0.3 |
|
|
Total items that will not be reclassified to the income statement |
|
|
|
0.9 |
|
–0.3 |
|
|
|
|
|
|
|
|
|
|
|
Total other comprehensive income |
|
|
|
14.3 |
|
–2.9 |
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income for the period |
|
|
|
19.9 |
|
4.4 |
|
|
- thereof attributable to shareholders of medmix Ltd |
|
|
|
19.1 |
|
4.4 |
|
|
- thereof attributable to non-controlling interests |
|
|
|
0.8 |
|
– |
|